Protected PCI Enables Safe and Effective Treatment of High-Risk and Complex Patients
Benefits of Protected PCI include:
- Improved outcomes through complete revascularization and reduction of repeat and staged procedures5
- Improvement in ejection fraction and heart failure symptoms1
- Significant reduction in the overall incidence of post-procedural acute kidney injury (AKI)2
- Fewer hypotensive events during the procedure1
- Reduction in peri-procedural MI and post-procedural MACCE3
- Treatment options for patients ineligible for surgery4
- Reduction in length of stay6
Read more about the procedural steps for the single-access technique that enables one access site for both the Impella CP® and an additional catheter.Download PDF
Ejection Fraction Improvement with Complete Revascularization
Mitul Patel, MD, FACC, FSCAI, from UC San Diego (UCSD), discusses the RESTORE EF study and a successful patient case from the study. The case was a 61-year-old male with diabetes, hypertension, and hyperlipidemia who had new-onset heart failure and severe three-vessel coronary artery disease (CAD).
Resources from the Education Library
Complete Revascularization Associated with Significant Improvement in LVEF and Long-Term Survival
This retrospective study was done at two centers in Rome and Verona, Italy using a prospectively maintained registry database.
Rapid and Safe Adoption of the New Single Access Technique
Duane Pinto, MD, MPH, discusses the new single access technique, designed to avoid an additional arterial access and reduce associated complications as well as make the procedure more rapid.
Complex Percutaneous Axillary Protected PCI Case
Watch Thom Dahle, MD, perform a high-risk PCI procedure recorded live from St. Cloud, MN, with panel commentary.
Abiomed Academy provides self-guided online product training for health care professionals of all experience levels and roles.
- O’Neill, W.W., et al. (2012). Circulation, 126(14), 1717-1727.
- Flaherty, M.P., et al. (2017). Circ Res, 120(4), 692-700.
- Dangas, G.D., et al. (2014). Am J Cardiol, 113(2), 222-228.
- Waldo, S.W., et al. (2014). Circulation, 130(25), 2295-2301.
- Burzotta, F., et al. (2019). J Interv Cardiol, 2019(5), 1-10.
- Maini, B., et al. (2014). Expert Rev Pharmacoecon Outcomes Res, 14(3), 403-416.